StemGenex, a provider of adult adipose-derived stem cell therapy, has named Jeremiah McDole, Ph.D., director of Clinical R&D.
As director, McDole is responsible for project planning and operational delivery of clinical programs in conjunction with overall management, administration and operation of the laboratory. He also will be responsible for management and development of regulatory compliance while striving to maximize the safety and efficacy of treatments. Further, McDole will drive the advancement of current and future techniques.
"I am a strong believer in cellular medicine and its ability to better patients' lives," said McDole. "Recent discoveries have made stem cells a multi-faceted vehicle to produce incredible advances in personalized therapy.”